» Authors » Stanislas Grassin-Delyle

Stanislas Grassin-Delyle

Explore the profile of Stanislas Grassin-Delyle including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 75
Citations 832
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lamy E, Roquencourt C, Zhou B, Salvator H, Moine P, Annane D, et al.
Anal Bioanal Chem . 2024 Jul; 416(22):4929-4939. PMID: 38980330
Exhaled breath volatilomics is a powerful non-invasive tool for biomarker discovery in medical applications, but compound annotation is essential for pathophysiological insights and technology transfer. This study was aimed at...
2.
Guilleminault L, Grassin-Delyle S, Mazzone S
Drugs . 2024 Jun; 84(7):763-777. PMID: 38904926
Refractory chronic cough is a disabling disease with very limited therapeutic options. A better understanding of cough pathophysiology has led to the development of emerging drugs targeting cough receptors. Recent...
3.
Salvator H, Lamy E, Roquencourt C, Bardin E, Devillier P, Grassin-Delyle S
Front Pharmacol . 2024 Jan; 14:1339835. PMID: 38269282
Although adherence to inhaled medication is critically important for treatment efficiency, around half of patients taking these drugs are non-adherent or make critical errors when using their delivery device. Segmental...
4.
Brollo M, Salvator H, Grassin-Delyle S, Glorion M, Descamps D, Buenestado A, et al.
Int Immunopharmacol . 2024 Jan; 128:111557. PMID: 38266451
Background And Purpose: Lung macrophages (LMs) are critically involved in respiratory diseases. The primary objective of the present study was to determine whether or not an adenosine analog (NECA) and...
5.
Roquencourt C, Lamy E, Bardin E, Devillier P, Grassin-Delyle S
J Breath Res . 2023 Nov; 18(1). PMID: 37917990
Volatilomics is the branch of metabolomics dedicated to the analysis of volatile organic compounds in exhaled breath for medical diagnostic or therapeutic monitoring purposes. Real-time mass spectrometry (MS) technologies such...
6.
Roquencourt C, Salvator H, Bardin E, Lamy E, Farfour E, Naline E, et al.
ERJ Open Res . 2023 Sep; 9(5). PMID: 37727677
Background: Although rapid screening for and diagnosis of coronavirus disease 2019 (COVID-19) are still urgently needed, most current testing methods are long, costly or poorly specific. The objective of the...
7.
Guilleminault L, Demoulin-Alexikova S, de Gabory L, Bruley des Varannes S, Brouquieres D, Balaguer M, et al.
Respir Med Res . 2023 Apr; 83:101011. PMID: 37087905
Patients with chronic cough experience a high alteration of quality of life. Moreover, chronic cough is a complex entity with numerous etiologies and treatments. In order to help clinicians involved...
8.
Shakur-Still H, Roberts I, Grassin-Delyle S, Chaudhri R, Geer A, Arribas M, et al.
BJOG . 2023 Apr; 130(10):1177-1186. PMID: 37019443
Objective: To examine the safety, efficacy and pharmacology of intravenous (IV), intramuscular (IM) and oral tranexamic acid (TXA) use in pregnant women. Design: Randomised, open-label trial. Setting: Hospitals in Pakistan...
9.
Ghazaly C, Biletska K, Thevenot E, Devillier P, Naline E, Grassin-Delyle S, et al.
J Breath Res . 2023 Feb; 17(2). PMID: 36749983
Early, rapid and non-invasive diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is needed for the prevention and control of coronavirus disease 2019 (COVID-19). COVID-19 mainly affects the...
10.
Shakur-Still H, Grassin-Delyle S, Muhunthan K, Ahmadzia H, Faraoni D, Arribas M, et al.
Int J Gynaecol Obstet . 2022 Jun; 158 Suppl 1:40-45. PMID: 35762806
Objective: To review available data on tranexamic acid (TXA) plasma concentration needed to inhibit fibrinolysis and the time to achieve this concentration when giving TXA by different routes in humans....